Aces Diagnostics Selected for Investment by AZ Advances at AzBio White Hat Investor Conference

Aces Diagnostics is proud to announce that it was the only company selected for investment at the prestigious AzBio White Hat Investor Conference. The decision was made following Aces Dx’s compelling pitch deck presentation, marking a significant milestone for the company.

​

AZ Advances, a prominent organization dedicated to fostering the growth of Arizona-based companies in the life sciences sector, chose Aces Diagnostics for its innovative approach to diagnostics. The company is honored to receive this recognition and looks forward to making a lasting impact in the healthcare industry. The event was attended by key Arizona policymakers, including several senators and influential figures in the state's life sciences community. Joan Gerber Walker, leader of AZBio, underscored the critical need for improved diagnostics for Lyme disease, a challenge Aces Diagnostics is poised to address through its cutting-edge solutions.

​

Aces Diagnostics is excited to be part of the effort to improve patient outcomes and contribute to the ongoing advancement of Lyme detection in Arizona and beyond.